Correlation Engine 2.0
Clear Search sequence regions
Bookmark Forward

QuickView for estrone (compound)


PubChem
Name: Estrone
PubChem Compound ID: 10401044
Description: An aromatized C18 steroid with a 3-hydroxyl group and a 17-ketone, a major mammalian estrogen. It is converted from ANDROSTENEDIONE directly, or from TESTOSTERONE via ESTRADIOL. In humans, it is produced primarily by the cyclic ovaries, PLACENTA, and the ADIPOSE TISSUE of men and postmenopausal women.
Molecular formula: C18H22O2
Molecular weight: 272.374 g/mol
DrugBank
Identification
Name: Estrone
Name (isomeric): DB00655
Drug Type: small molecule
Description: An aromatized C18 steroid with a 3-hydroxyl group and a 17-ketone, a major mammalian estrogen. It is converted from ANDROSTENEDIONE directly, or from TESTOSTERONE via ESTRADIOL. In humans, it is produced primarily by the cyclic ovaries, PLACENTA, and the ADIPOSE TISSUE of men and postmenopausal women.
Brand: Femestrone Injection, Hiestrone, Estrona [INN-Spanish], Estrin, Oestroform, Hormovarine, OVEX, Follestrine, Oestronum, Thelykinin, GSS 33, Ketohydroxyoestrin, Unden, Ketodestrin, Ovifollin, Oestrone, Estrusol, Ketohydroxy-Estratriene, Fermidyn, Folliculin, Ketophydroxyestrin, Hormestrin, Glandubolin, Aquacrine, Estrona, Kestrone, Folikrin, Folisan, Follicular Hormone, Tokokin, Menformon A, Follidrin, Sinafid M-48, Follicunodis, Esterone, Folliculine Benzoate, Ketohydroxyestrin, Estrona [Spanish], Oestrone [Steroidal Oestrogens], Estrone-A, Folliculine, Kolpon, Estronum [INN-Latin], Oestrin, Follestrol, Menformon, Disynformon, Hormofollin, Femidyn, Femestrone Inj., Cristallovar, Solliculin, Mestronaq, Theelin, Thynestron, Estrogenic Substance, Wynestron, Crystogen, Estron, Estrol, Destrone, Folipex, Crinovaryl, Thelestrin, Wynestronpencap M, Perlatan, Penncap M, Menagen, Endofolliculina, Estrugenone, Estrone [Usan:Inn], Oestroperos, Estrovarin
Brand name mixture: Cimicifuga Plex(Caulophyllum Thalictroides + Cimicifuga Racemosa + Copper + Cotton Plant + Estrone + Histamine Dihydrochloride + Hypothalamus + Magnesium Phosphate Dibasic + Pituitary Whole + Platinum + Sepia Officinalis L + Thyroid), Holis 98(Dioscorea Vilosa + Estrone + Salvia + Saw Palmetto)
Category: Estrogens, Osteoporosis Prophylactic, Antineoplastic Agents, Anti-menopausal Agents
CAS number: 53-16-7
Pharmacology
Indication: For management of perimenopausal and postmenopausal symptoms.
Pharmacology:
Estrone, a synthetically prepared or naturally occurring steroidal estrogen obtained from pregnant equine urine, is the primary circulating estrogen after menopause. Estrone is naturally derived from the peripheral conversion of androstenedione by an aromatase enzyme found in adipose tissues and is converted to estradiol in peripheral tissues. The ...
show more »
Mechanism of Action:
Estrogens enter the cells of responsive tissues (e.g. female organs, breasts, hypothalamus, pituitary) where they interact with estrogen receptors. Hormone-bound estrogen receptors dimerize, translocate to the nucleus of cells and bind to estrogen response elements (ERE) of genes. Binding to ERE alters the transcription rate of affected genes. Estr...
show more »
Absorption: 43%
Protein binding: > 95%
Biotransformation: Hepatic.
Half Life: 19 hours
Toxicity: Symptoms of overdose include nausea and vomiting. Estrogen related side effects include nausea, breast tenderness, fluid retention and edema, headaches and/or migraines, chloasma and poor contact lens fit. Estrogen hormone deficiency is associated with breakthrough bleeding, hypomenorrhea, irritability, depression and menopausal symptoms. Withdrawal bleeds may occur in females.
Affected organisms: Humans and other mammals
Interactions
Drug interaction:
PrednisoloneThe estrogenic agent, estrone, may increase the effect of the corticosteroid, prednisolone.
PhenobarbitalThe enzyme inducer, phenobarbital, decreases the effect of the hormone agent, estrone.
PrednisoneThe estrogenic agent, estrone, may increase the effect of corticosteroid, prednisone.
TipranavirEstropipate may increase the adverse dermatological effects (i.e. skin rash) of Tipranavir. Tipranavir may decrease the serum concentration Estropipate. Monitor for estrogen deficiency during concomitant therapy.
PhenytoinThe enzyme inducer, phenytoin, decreases the effect of the hormone agent, estrone.
show more »

Targets


Enzymes


Transporters


Carriers